FY2025 EPS Estimates for VERA Lowered by Cantor Fitzgerald
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Cantor Fitzgerald dropped their FY2025 earnings per share estimates for shares of Vera Therapeutics in a research report issued to clients and investors on Monday, May 12th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will post earnings per share of ($2.79) for the year, […]
